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Helicobacter pylori infection (HPI) is a prevalent infectious disease associ-
ated with gastric ulcer, gastric cancer, and many nongastrointestinal dis-
orders. To identify genes that may serve as microbial markers for HPI, we
performed shotgun metagenomic sequencing of fecal samples from 313
Chinese volunteers who had undergone a C14 breath test. Through com-
paring differences in intestinal microbial community structure between
H. pylori-positive and H. pylori-negative individuals, we identified 58 HPI-
associated microbial species (P < 0.05, Wilcoxon test). A classifier based
on microbial species markers showed high diagnostic ability for HPI
(AUC = 0.84). Furthermore, levels of gut microbial vitamin B12 (VB12)
biosynthesis and plasma VB12 were significantly lower in H. pylori-positive
individuals compared with H. pylori-negative individuals (P < 0.05, Wil-
coxon test). This study reveals that certain alterations in gut microbial spe-
cies and functions are associated with HPI and shows that gut microbial
shift in HPI patients may indirectly elevate the risk of VB12 deficiency.
Helicobacter pylori, a microaerophilic Gram-negative
bacterium, was first isolated in 1984 from patients with
chronic active gastritis [1]. H. pylori infection (HPI) is
a prevalent infectious disease with a global prevalence
of 44.3% [2] and can lead to gastrointestinal diseases
such as peptic ulcer, atrophic gastritis, and gastric car-
cinoma [3]. Although H. pylori predominantly colo-
nizes the stomach, previous epidemiological studies
have reported that HPI correlates with certain extra-
gastric diseases [4], including vitamin B12 (VB12) defi-
ciency [5–7], iron deficiency anemia [8], inflammatory
bowel disease [9], and even neurodegenerative diseases
[4].
Several previous studies have revealed that HPI cor-
relates with a shift in gastrointestinal microbiota [10–
13], immune responses [14], and metabolic imbalances
of host [6,7]. The microbiota of Mongolian gerbil gas-
trointestinal tracts were distinctly altered after long-
term infection with the H. pylori B8 wild-type strain,
with the luminal loads of Escherichia coli and entero-
cocci in the cecum and Bacteroides/Prevotella spp. in
the colon strikingly elevated [10]. In mice, continuous
Abbreviations
AUC, area under the receiver operating curve; BMI, body mass index; HPI, Helicobacter pylori infection; IGC, integrated gene catalog;
IMG, integrated microbial genomes and microbiomes database; KEGG, Kyoto encyclopedia of genes and genomes; LC-MS/MS, liquid
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HPI alters the gastric and intestinal microbiota com-
munity structure. Additionally, the infection causes
increased expression of immune response-related genes
in gastric and pulmonary tissues [13]. In humans, the
relative abundances of dominant phyla in the gut of
HPI-positive individuals, including Bacteroidetes, Fir-
micutes, and Proteobacteria, are significantly different
from HPI-negative individuals and may correlate with
gastric lesions [12]. Usually, alterations in the micro-
biome are accompanied by differences in microbial
functions; the relative abundance of 19 predicted gut
microbial pathways is significantly different between
H. pylori-positive and H. pylori-negative individuals
[11]. Besides the effect on host gastrointestinal
microbes, persistent infection with H. pylori can cause
detrimental inflammatory processes [14], and epidemio-
logical studies have revealed that HPI correlates with
lower VB12 levels in the blood [6,7].
Previous HPI-related intestinal microbiome studies
used 16S rRNA amplicon sequencing, which may be
limiting because of the inadequate resolution for
microbial taxonomy and function [15]. In addition,
primer selection and PCR amplification can introduce
bias when quantifying taxa abundance [16]. Therefore,
it remains unclear how many bacterial genes and spe-
cies could serve as microbial markers for HPI and
how a shift in gut microbiome alters the host’s meta-
bolism and immune responses.
In this study, we performed a shotgun metagenomic
sequencing of fecal samples from 313 Chinese volun-
teers who had undergone a C14 breath test. We com-
pared the differences in intestinal microbial
community structure between H. pylori-positive and
H. pylori-negative individuals and identified the gut
microbial species and functions associated with HPI.
In addition, the blood metabolite data of the 313 vol-
unteers were collected. To further investigate how HPI
influences host health, we analyzed the alterations of
blood metabolite levels to explore the potential physio-
logical effects of HPI mediated by gut microbes.
Materials and methods
Study samples
Fresh stool samples for the metagenomic sequencing were
obtained from volunteers recruited in the Yantian District,
Shenzhen, China. The C14 breath test to determine HPI
status and other blood biochemistry level assessments were
performed in a local hospital, and plasma VB12 levels were
quantified using LC-MS/MS (Table S1). None of the vol-
unteers had taken any antibiotics within the previous
3 months. In addition, volunteers with serious illnesses,
metabolic diseases, and pregnancies were excluded from the
study. The samples were divided into H. pylori-positive and
H. pylori-negative groups according to the C14 test results.
The summary statistics of the study samples are provided
in Table 1.
Written informed consent was obtained from all patients
in accordance with the Declaration of Helsinki. This study
was approved by the Institutional Review Board on
Bioethics and Biosafety of BGI (BGI-IRB, Shenzhen
518083, China) with approval number BGI-IRB 15079.
Comparisons of phenotypes and biochemical
levels
Body mass index (BMI), age, clinical indices, and plasma
levels of VB12 were compared between the H. pylori-posi-
tive and H. pylori-negative groups using the Wilcoxon test.
The gender ratio of each group was compared using the
chi-square test.
Metagenomic sequencing
Fecal DNA was extracted following the MetaHIT protocol
[17], and then, single-end metagenomic sequencing was per-
formed using the BGISEQ-500 platform. The low-quality
reads were discarded, and the host DNA was removed
based on the human reference genome hg19 using
SOAP2.22 [18] (identity ≥ 0.9).
Profile generation
The clean reads were mapped to the integrated gene catalog
(IGC, http://meta.genomics.cn) using SOAP 2.22 (identity
≥ 0.95) [19], relative gene abundance profiles were pro-
duced; then, the species, genus, KEGG module, and path-
way relative abundance profiles were generated, according
to the Integrated Microbial Genome reference database
(IMG, https://img.jgi.doe.gov/) [20].
Rarefaction analysis
Rarefaction analysis was performed to assess the gene rich-
ness of H. pylori-positive and H. pylori-negative samples.
For a given number of samples, we performed random
Table 1. Basic information of study volunteers. F, females; M,
males
All Positive Negative
Number 313 (148 F,
165 M)
128 (59 F, 69 M) 185 (89 F, 96 M)
Age 20–66 (28.14) 20–44 (27.77) 21–66 (28.39)
BMI 15–38.6 (21.39) 15–38.6 (21.63) 15.8–29.1 (21.23)
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sampling 100 times in the cohort with replacement and esti-
mated the total number of genes that could be identified
from these samples.
Enterotype and diversity analysis
The enterotype of each stool sample was analyzed using a
PAM-based method on genus profiles [17,21]. The Shannon
index was used to determine within-individual alpha-diver-
sities in gene, species, genus, and phylum level. The Bray–
Curtis distance, calculated in R 3.4.2 (vegan package) [22],
was used to estimate the between-individuals beta-diversity
at the gene level.
Metagenome-wide association study and
metagenomics linkage group-based analysis
The marker genes that were significantly different in rela-
tive abundance between the H. pylori-positive and H. py-
lori-negative groups were identified using the Wilcoxon test.
The marker genes were then clustered into metagenomics
linkage groups (MLGs) according to their abundance varia-
tion across all samples. The taxonomic assignment and
abundance profiles of the MLGs were then obtained
[17,23]. The MLGs with gene cluster number ≥ 100 were
selected. To identify confounding factors, we first calcu-
lated correlations of MLG abundances with age, BMI, and
gender. Wilcoxon test would be used for MLGs which are
not correlated with any one of the three factors, to com-
pare the abundance between HPI-positive and HPI-negative
groups. Otherwise, logistic model would be used to remove
confounding effects. The co-presented relationships among
the MLGs were calculated using Spearman’s rank correla-
tion and visualized in Cytoscape 3.6.0.
A classification model using MLG abundance profiles in
gut microbiome was established for the prediction of HPI
status. Tenfold cross-validation was performed, based on a
random forest model (R 3.4.2, randomForest 4.6-10 pack-
age [24]). The training set consisted of 250 randomly
selected samples (152 negative and 98 positive) from a total
of 313 samples, and the test set was comprised of the
remaining 63 samples (33 negative and 30 positive). The
performance of the classifier was assessed by ROC curve
separately in the training set and test set. The probability
of being H. pylori-positive was calculated, and the ROC
curve was drawn using the pROC package [24] for R 3.4.2.
KEGG analysis
Differentially enriched KEGG modules were identified
according to their reporter scores [23]. A reporter score of
Z ≥ 1.6 (90% confidence according to a normal distribu-
tion) was used as the detection threshold for significantly
differentiating modules.
Results
Overview of gut microbiome
To determine whether HPI accompanies with changes
in the gut microbiome, metagenomic sequencing was
performed on 313 stool samples from volunteers, of
which 128 were H. pylori-positive, and 185 were
H. pylori-negative (Table 1). The distribution of BMI
and age in the HPI-negative and HPI-positive groups
is shown in Fig. S1, and there was no significant dif-
ference in BMI and age between the two groups,
whereas there was a significant difference (v2 test,
P < 0.05) in gender ratio between the two groups. The
shotgun metagenomic sequencing was carried out
using the BGISEQ-500 platform and generated an
average of 42 million single-end reads per sample. To
ensure that our sample size was sufficient for this
study, rarefaction analysis was carried out for the
H. pylori-positive and H. pylori-negative groups, and
the results showed that the gene richness approached
saturation in each group and showed higher richness
in the H. pylori-positive group (Fig. 1A). Referring to
previous human gut microbiome metagenomic studies,
we determined that the sample size in our study was
sufficient [17,23,25].
The richness and diversity of the gut microbiota in
the two groups were investigated. In contrast to the
results of stomach microbial communities, there was
no significant difference in the gene richness, species
richness, and the within-sample diversity between the
H. pylori-positive and H. pylori-negative groups (Wil-
coxon test, P > 0.05; Fig. S2). On the other hand, at
the gene level, the intersample diversity was signifi-
cantly higher in the H. pylori-positive group compared
with the H. pylori-negative group (Wilcoxon test,
P < 0.05; Fig. 1B). Enterotype is also a general char-
acteristic of the human gut microbiota [21,23,26]. We
divided the samples into two enterotypes (or clusters)
using a PAM-based method; the H. pylori-positive and
H. pylori-negative groups both contained two entero-
types (Fig. 1C). However, the H. pylori-positive group
had a higher proportion of enterotype 1, which con-
tains a high level of Prevotella, whereas the healthy
H. pylori-negative group had a higher proportion of
enterotype 2, which is dominated by Bacteroides (v2
test, P < 0.05; Fig. 1D).
Metagenome-wide association study and
metagenomics linkage group-based analysis
In order to investigate the HPI-related signatures of
the gut microbiome, we adopted the MLG method to
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cluster the genes with significant abundance differences
into taxa. We identified 189,771 genes that were differ-
entially enriched in H. pylori-positive or H. pylori-
negative groups (adjusted P < 0.1, Wilcoxon test),
approximately 1.9% of the total gene numbers in the
integrated gene catalog (IGC). Approximately 56.3%
and 43.7% of the gene markers were significantly
enriched in the H. pylori-positive group and H. pylori-
negative group, respectively. There were 58 MLGs that
had significantly different relative abundances between
the H. pylori-positive and H. pylori-negative groups
(adjusted P < 0.05, Wilcoxon test; Fig. 2A,B; Tables
S2 and S3). Among the differential MLGs, 31 were
enriched in the H. pylori-positive group and 27 were
enriched in the H. pylori-negative group.
We observed that the MLGs that were annotated as
Prevotella copri, which is a proinflammatory bacterium
and has been shown to correlate with the onset and
development of rheumatoid arthritis (RA) [25], were
enriched in H. pylori-positive individuals. In addition,
the relative abundances of Enterobacter cloacae and
Klebsiella pneumoniae, two infectious pathogenic bacte-
ria that can cause bacteremia and septicemia com-
monly associated with hospital infections [27], were
clustered together and also enriched in the H. pylori-
positive group. The relative abundances of Sutterella
wadsworthensis, B. vulgatus, and E. coli were signifi-
cantly higher in the H. pylori-negative group compared
with the H. pylori-positive group. In contrast to P. co-
pri, S. wadsworthensis has been found to be enriched
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Fig. 1. Overall observations of gut microbiome. (A) The rarefaction curves of gut microbial genes in H. pylori-negative and H. pylori-positive
group. (B) Between-group b-diversity of the two groups on gene level (P < 0.01, Wilcoxon test). (C) The principal coordinate analysis (PCoA)
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in people without RA [25]. Additionally, the P. copri
cluster that was enriched in the H. pylori-positive
group negatively correlated with H. pylori-negative-
enriched MLGs (Fig. 2B), indicating that, in H. pylori-
positive individuals, the gut microbial network shifts via
interspecies interactions.
To evaluate the possibility of determining HPI using
gut microbial markers, we constructed a classifier
based on the random forest model. The validated opti-
mal model selected 30 MLG markers, and the area
under the ROC was 86.82% in the training set and
84.09% in the test set (Fig. 3A–D), indicating that gut
microbial MLGs can be used to classify whether a
subject has been infected with H. pylori.
KEGG analysis
To explore the association between the HPI and alter-
ations in human gut microbiome function, the
microbial genes were mapped to KEGG modules and
pathways; the KEGG pathways and modules with
levels significantly different between the H. pylori-posi-
tive and H. pylori-negative groups are listed in Tables
S4 and S5. The genes with functions related to cofac-
tor and vitamin biosynthesis, cellular processes, and
human diseases were enriched in different groups
(Fig. 4A–C). In particular, the level of KEGG mod-
ules for VB12 biosynthesis was significantly diminished
in the H. pylori-positive group (Fig. 4A). After then,
comparison of the plasma VB12 concentrations
between the two groups revealed that the H. pylori-
positive group had significantly lower VB12 levels than
the H. pylori-negative group (Fig. 4D), indicating that
infection with H. pylori may increase the risk of VB12
deficiency. The differential genes assigned to KEGG
pathways involved in flagella assembly and bacterial
chemotaxis were diminished in the HPI-associated
microbiome (Fig. 4B), indicating the weaker mobility
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and chemotaxis of intestinal microbes in H. pylori-
positive individuals. Additionally, among the 11
enriched disease-related KEGG pathways, nine were
enriched in the H. pylori-positive group, of which four
were related to infectious diseases (Fig. 4C).
Discussion
The current study identified HPI-related gut micro-
biome alterations and provided a catalog of changes
for further research. In addition, a classifier to discrim-
inate HPI status using microbial markers was con-
structed and evaluated. Further analyses on microbial
functional profiles and metabolite level comparisons,
revealed the diminished level of blood VB12 and
decreased microbial VB12 biosynthesis capacity in
HPI-positive individuals, indicating that HPI-related
VB12 deficiency could be caused by imbalance of the
gut microbiome.
The relative abundance of MLGs, annotated as
P. copri, was significantly enriched in H. pylori-
positive individuals. P. copri is an immune-relevant
gut microbe. It has been reported that the continuous
colonization of H. pylori in the stomach induces the
host immune response [4,10]. There is a complex inter-
action between the intestinal microbes and the host;
gut microbial communities are crucial for host immune
system function, and in turn, the immune environment
affects the gut microbial structure [28]. P. copri is very
prosperous in a proinflammatory gastrointestinal
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environment and further increases the level of inflam-
mation [29]. RA, which is a prevalent systemic autoim-
mune disease, has been shown to associated with gut
microbiome dysbiosis, and P. copri is associated with
the onset and severity of rheumatoid arthritis [25,30].
The enrichment of P. copri in H. pylori-positive indi-
viduals may correlate with the change of intestinal
immune environment.
We observed that the VB12 biosynthesis module
was depleted in the H. pylori-positive group, and
plasma VB12 concentration was also significantly
lower in the H. pylori-positive group compared with
the H. pylori-negative group. Biologically, VB12 is a
type of cobalt corrinoid, and as humans and most
other animals are incapable of VB12 production, it is
exclusively produced by the microorganisms, particu-
larly anaerobes [31]. Substantial previous epidemiologi-
cal studies have revealed that HPI correlates with
lower VB12 levels and even VB12 deficiency [6,7]. Our
current results suggest that the HPI-related dysbiosis
of intestinal microbiota can affect the production of
VB12 in the human intestine. Previous research infers
that gastric sinusitis, caused by HPI, may progress to
type B chronic gastritis, accompanied by decreased
gastric acid secretion, which leads to malabsorption of
VB12 [7,32]. Therefore, both the production and
absorption capacity of VB12 can be weakened by HPI,
increasing the risk of VB12 deficiency.
There are some limitations to this study that need to
be addressed. The effects of HPI on the host have
individual and population variations, and strain speci-
ficity. These differences need to be addressed in subse-
quent studies with a larger sample size. Further studies
should also include host proteomics, metabolomics,
and other data for multiomics integrated analysis,
which could then furtherly reveal the mechanisms by
which H. pylori impacts the host.
In conclusion, our study sequenced 313 fecal sam-
ples using the metagenomic shotgun method and ana-
lyzed the differences between H. pylori-positive and
H. pylori-negative groups. It shows that HPI is associ-
ated with changes in human intestinal microbial com-
position and function in the Chinese population. Also,
the abundance of the immunologically related bacteria
P. copri was significantly different between the two
groups. In the H. pylori-positive group, the levels of
flagella assembly and bacterial chemotaxis-related
pathways were significantly depleted, and these intesti-
nal changes in the H. pylori-positive group may have
further effects on the host. The lower level of VB12
biosynthesis module was associated with the lower
VB12 concentrations in the blood of H. pylori-positive
individuals, indicating that HPI-related gut microbiota
dysbiosis can increase the risk of VB12 deficiency. Our
study provides new clues into the interactions between
H. pylori and host gastrointestinal microecology.
Acknowledgements
We thank the participants in this study for their collab-
oration. This work was supported by BGI-Shenzhen,
Shenzhen 518083, China.
Conflict of interest
The authors declare no conflict of interest.
Author contributions
DW designed the study. XZ, HY, XL, and RW man-
aged the project. YZ, YL, and DW contributed to the
acquisition of sample and clinical data. DW, QD, YL,
ST, and QW performed data analyses. DW wrote the
paper. DW, YL, and ZH revised the paper. All
authors approved the final paper.
References
1 Marshall BJ and Warren JR (1984) Unidentified curved
bacilli in the stomach of patients with gastritis and
peptic ulceration. Lancet 1, 1311–1315.
2 Zamani M, Ebrahimtabar F, Zamani V, Miller WH,
Alizadeh-Navaei R, Shokri-Shirvani J and Derakhshan
MH (2018) Systematic review with meta-analysis: the
worldwide prevalence of Helicobacter pylori infection.
Aliment Pharmacol Ther 47, 868–876.
3 Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP,
Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A,
Atherton J, Graham DY et al. (2016) Management of
Helicobacter pylori infection-the Maastricht V/Florence
consensus report. Gut 66, 6–30.
4 Franceschi F, Zuccala G, Roccarina D and Gasbarrini
A (2014) Clinical effects of Helicobacter pylori outside
the stomach. Nat Rev Gastroenterol Hepatol 11,
234–242.
5 Kadhim G, Shikh M, Omar H and Ismail A (2018)
Vitamin B12 deficiency in Helicobacter pylori infected
patients. OALib 05, 1–4.
6 Tamura A, Fujioka T and Nasu M (2002) Relation of
Helicobacter pylori infection to plasma vitamin B12,
folic acid, and homocysteine levels in patients who
underwent diagnostic coronary arteriography. Am J
Gastroenterol 97, 861–866.
7 Shuval-Sudai O and Granot E (2003) An association
between Helicobacter pylori infection and serum vitamin
B12 levels in healthy adults. J Clin Gastroenterol 36,
130–133.
1558 FEBS Open Bio 9 (2019) 1552–1560 ª 2019 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
HPI-related gut microbial alterations D. Wang et al.
8 DuBois S and Kearney DJ (2005) Iron-deficiency
anemia and Helicobacter pylori infection: a review of
the evidence. Am J Gastroenterol 100, 453–459.
9 Casta~no-Rodrıguez N, Kaakoush NO, Lee WS and
Mitchell HM (2017) Dual role of Helicobacter and
Campylobacter species in IBD: a systematic review and
meta-analysis. Gut 66, 235–249.
10 Heimesaat MM, Fischer A, Plickert R, Wiedemann T,
Loddenkemper C, G€obel UB, Bereswill S and Rieder G
(2014) Helicobacter pylori induced gastric
immunopathology is associated with distinct microbiota
changes in the large intestines of long-term infected
Mongolian gerbils. PLoS ONE 9, 1–11.
11 Chen L, Xu W, Lee A, He J, Huang B, Zheng W, Su
T, Lai S, Long Y, Chu H et al. (2018) The impact of
Helicobacter pylori infection, eradication therapy and
probiotic supplementation on gut microenvironment
homeostasis: an open-label, randomized clinical trial.
EBioMedicine 35, 87–96.
12 Gao J-J, Zhang Y, Gerhard M, Mejias-Luque R,
Zhang L, Vieth M, Ma J-L, Bajbouj M, Suchanek S,
Liu W-D et al. (2018) Association between gut
microbiota and Helicobacter pylori-related gastric
lesions in a high-risk population of gastric cancer. Front
Cell Infect Microbiol 8, 1–12.
13 Kienesberger S, Cox LM, Livanos A, Zhang XS,
Chung J, Perez-Perez GI, Gorkiewicz G, Zechner EL
and Blaser MJ (2016) Gastric Helicobacter pylori
infection affects local and distant microbial populations
and host responses. Cell Rep 14, 1395–1407.
14 Cadamuro ACT, Rossi AFT, Maniezzo NM and Silva
AE (2014) Helicobacter pylori infection: host immune
response, implications on gene expression and
MicroRNAs. World J Gastroenterol 20, 1424–1437.
15 Wang J and Jia H (2016) Metagenome-wide association
studies: fine-mining the microbiome. Nat Rev Microbiol
14, 508–522.
16 Tremblay J, Singh K, Fern A, Kirton ES, He S, Woyke
T, Lee J, Chen F, Dangl JL and Tringe SG (2015)
Primer and platform effects on 16S rRNA tag
sequencing. Front Microbiol 6, 1–15.
17 Wang JJ, Qin J, Li Y, Cai Z, Li SS, Zhu J, Zhang F,
Liang S, Zhang W, Guan Y et al. (2012) A
metagenome-wide association study of gut microbiota
in type 2 diabetes. Nature 490, 55–60.
18 Luo R, Liu B, Xie Y, Li Z, Huang W, Yuan J, He G,
Chen Y, Pan Q, Liu Y et al. (2012) SOAPdenovo2: an
empirically improved memory-efficient short-read de
novo assembler. Gigascience 1, 18.
19 Li J, Wang J, Jia H, Cai X, Zhong H, Feng Q,
Sunagawa S, Arumugam M, Kultima JR, Prifti E
et al. (2014) An integrated catalog of reference genes
in the human gut microbiome. Nat Biotechnol 32,
834–841.
20 Chen IMA, Markowitz VM, Chu K, Palaniappan K,
Szeto E, Pillay M, Ratner A, Huang J, Andersen E,
Huntemann M et al. (2017) IMG/M: integrated
genome and metagenome comparative data
analysis system. Nucleic Acids Res 45,
D507–D516.
21 Arumugam M, Raes J, Pelletier E, Le Paslier D,
Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T,
Batto J-M et al. (2011) Enterotypes of the human gut
microbiome. Nature 473, 174–180.
22 Zapala MA and Schork NJ (2006) Multivariate
regression analysis of distance matrices for testing
associations between gene expression patterns and
related variables. Proc Natl Acad Sci USA 103,
19430–19435.
23 Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z,
Zhang D, Xia H, Xu X, Jie Z et al. (2015) Gut
microbiome development along the colorectal adenoma-
carcinoma sequence. Nat Commun 6, 6528.
24 Liaw A and Wiener M (2002) Classification and
regression by randomForest. R News 2, 18–22.
25 Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D,
Wu X, Li JJJ, Tang L, Li YYY et al. (2015) The oral
and gut microbiomes are perturbed in rheumatoid
arthritis and partly normalized after treatment. Nat
Med 21, 895–905.
26 Costea PI, Hildebrand F, Arumugam M, B€ackhed F,
Blaser MJ, Bushman FD, de Vos WM, Ehrlich SD,
Fraser CM, Hattori M et al. (2018) Enterotypes in the
landscape of gut microbial community composition.
Nat Microbiol 3, 8–16.
27 Peleg AY and Hooper DC (2010) Hospital-acquired
infections due to gram-negative bacteria. N Engl J Med
362, 1804–1813.
28 Rooks MG and Garrett WS (2016) Gut microbiota,
metabolites and host immunity. Nat Rev Immunol 16,
341–352.
29 Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda
C, Bielski C, Rostron T, Cerundolo V, Pamer EG,
Abramson SB et al. (2013) Expansion of intestinal
Prevotella copri correlates with enhanced susceptibility
to arthritis. eLife 2, e01202.
30 Pianta A, Arvikar S, Strle K, Drouin EE, Wang Q,
Costello CE and Steere AC (2017) Evidence of the
immune relevance of Prevotella copri, a gut microbe, in
patients with rheumatoid arthritis. Arthritis Rheumatol
69, 964–975.
31 LeBlanc JG, Milani C, de Giori GS, Sesma F, van
Sinderen D and Ventura M (2013) Bacteria as vitamin
suppliers to their host: a gut microbiota perspective.
Curr Opin Biotechnol 24, 160–168.
32 Stopeck A (2000) Links between Helicobacter pylori
infection, cobalamin deficiency, and pernicious anemia.
Arch Intern Med 160, 1229.
1559FEBS Open Bio 9 (2019) 1552–1560 ª 2019 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
D. Wang et al. HPI-related gut microbial alterations
Supporting information
Additional supporting information may be found
online in the Supporting Information section at the end
of the article.
Fig. S1. Distribution of BMI and age. (a) Distribution
of age. (b) Distribution of BMI.
Fig. S2. Alpha diversity in gene, species, genus, and
phylum levels. (a) Alpha diversity in gene level (b)
Alpha diversity in species level. (c) Alpha diversity in
genus level. (d) Alpha diversity in phylum level.
Table S1. Phenotype of all volunteers.
Table S2. The information for all MLGs containing
more than 100 genes.
Table S3. The profile of MLGs contains more than
100 genes.
Table S4. Differentially enriched KO pathways
between H. pylori positive and negative group (re-
porter score of ≥1.6).
Table S5. Differentially enriched KO modules between
H. pylori positive and negative group (reporter score
of ≥1.6).
1560 FEBS Open Bio 9 (2019) 1552–1560 ª 2019 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.
HPI-related gut microbial alterations D. Wang et al.
